The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
Pre-existing cross-reactive immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins in infection-naive subjects have been described by several studies. In particular, regions of high homology between SARS-CoV-2 and common cold coronaviruses have been highlighted as...
Автори: | Murray, SM, Ansari, AM, Frater, J, Klenerman, P, Dunachie, S, Barnes, E, Ogbe, A |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
Springer Nature
2022
|
Схожі ресурси
Схожі ресурси
-
SARS-CoV-2 antibody responses post-vaccination in UK healthcare workers with pre-existing medical conditions: a cohort study
за авторством: Ward, V, та інші
Опубліковано: (2022) -
SARS-CoV-2 antibody responses post-vaccination in UK healthcare workers with pre-existing medical conditions: a cohort study
за авторством: Eleanor Barnes, та інші
Опубліковано: (2022-12-01) -
Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination
за авторством: Caiqin Hu, та інші
Опубліковано: (2022-09-01) -
IgM responses following SARS-CoV-2 vaccination: insights into protective and pre-existing immunity
за авторством: Judith Fraussen
Опубліковано: (2022-03-01) -
Cellular immunity to SARS-CoV-2 following intrafamilial exposure in seronegative family members
за авторством: Cecilia Jay, та інші
Опубліковано: (2023-08-01)